A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2002
10/29/2002	US6472403 αV integrin receptor antagonists
10/29/2002	US6472375 DNA vaccine and methods for its use
10/29/2002	US6472374 Endometrial function
10/29/2002	US6472368 Compounds and methods for modulating adhesion molecule function
10/29/2002	US6472367 Compounds and methods for modulating OB-cadherin mediated cell adhesion
10/29/2002	US6472213 Shuttle vectors for the introduction of DNA into mycobacteria and utilization of such bacteria as vaccines
10/29/2002	US6472195 Human kallikrein
10/29/2002	US6472183 Immunity against Actinobacillus pleuropneumoniae's RTX toxins APX
10/29/2002	US6472181 Hybrid matrix implants and explants
10/29/2002	US6472159 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine
10/29/2002	US6471996 Lactone and lactide copolymer; copolymer of lactic acid, glycolic acid, and serine; drug delivery to immune systen
10/29/2002	US6471978 Localized use of nitric oxide-adducts to prevent internal tissue damage
10/29/2002	US6471967 Recombinant intracellular pathogen vaccines and methods for use
10/29/2002	US6471966 Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof
10/29/2002	US6471965 Herpes simplex virus, human cytomegalovirus, epstein-barr virus
10/29/2002	US6471964 Designated as structural protein-1 (sp-1), the isolated sp-1 protein, and use of the nucleic acid and/or protein for diagnostic or vaccine purposes
10/29/2002	US6471963 Pure pancreatic islet cell membrane antigen or epitope thereof that can bind to islet cell surface antibodies (icsa).
10/29/2002	US6471962 Monoclonal antibodies for infectious bursal disease, vaccines and assays for use therewith
10/29/2002	US6471959 Human transferase
10/29/2002	US6471957 Canine IL-4 immunoregulatory proteins and uses thereof
10/29/2002	CA2221242C Viral agent associated with mystery swine disease
10/29/2002	CA2173102C Dna sequence coding for a bmp receptor
10/29/2002	CA2045552C Cancer related haptoglobin
10/29/2002	CA2014486C Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyltrithio group
10/24/2002	WO2002084294A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/24/2002	WO2002084249A2 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	WO2002083956A1 Compositions and methods for the therapy and diagnosis of breast cancer
10/24/2002	WO2002083950A1 Methods and compositions for treating cardiovascular disease using 10218
10/24/2002	WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002	WO2002083921A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	WO2002083919A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002	WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	WO2002083903A2 West nile virus epitopes and uses thereof
10/24/2002	WO2002083890A2 Use of clya hemolysin for excretion of fusion proteins
10/24/2002	WO2002083879A2 Immunotherapy based on dendritic cells
10/24/2002	WO2002083874A2 Endothelial cell expression patterns
10/24/2002	WO2002083866A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
10/24/2002	WO2002083860A2 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/24/2002	WO2002083859A2 Surface proteins of streptococcus pyogenes
10/24/2002	WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	WO2002083854A2 Antibodies to vla-1
10/24/2002	WO2002083843A2 Outer membrane associated polypeptides
10/24/2002	WO2002083738A1 Cyclic single strand trispecific antibody
10/24/2002	WO2002083737A1 Anti pilyrosporum ovale lgy and its uses
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083727A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid
10/24/2002	WO2002083725A1 Novel stress protein with chaperone activity
10/24/2002	WO2002083724A1 Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens
10/24/2002	WO2002083723A2 Polypeptides from h. influenzae homologous to a surface-exposed protein of neisseria meningitidis
10/24/2002	WO2002083714A2 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby
10/24/2002	WO2002083711A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
10/24/2002	WO2002083708A2 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083216A1 Method of intradermally injecting substances
10/24/2002	WO2002083187A1 Systems and methods for inducing mixed chimerism
10/24/2002	WO2002083181A1 Novel compositions and uses therefor
10/24/2002	WO2002083172A1 Methods for inhibiting hiv-1 infection
10/24/2002	WO2002083170A1 Vaccines including as an adjuvant type 1 ifn and processes related thereto
10/24/2002	WO2002083169A1 Modified staphylococcal enterotoxins and expression systems therefore
10/24/2002	WO2002083100A1 Liposomes consisting mainly of cholesterol
10/24/2002	WO2002083079A2 Aerosol compositions containing formoterol for delivery to the lungs via nebulization
10/24/2002	WO2002083077A2 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
10/24/2002	WO2002083072A2 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
10/24/2002	WO2002083069A2 Recombinant proteins of orientia tsutsugamushi
10/24/2002	WO2002083068A2 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
10/24/2002	WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002	WO2002083058A2 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
10/24/2002	WO2002083030A2 Bifunctional energy-reversible acyl-compositions
10/24/2002	WO2002074244A3 Transcutaneous immunostimulation
10/24/2002	WO2002066077A3 Modulated release particles for aerosol delivery
10/24/2002	WO2002064057A3 Use of cell penetrating peptides to generate antitumor immunity
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002058714A3 Methods and agents modulating upa/upar activity
10/24/2002	WO2002056830A3 The use of immature dendritic cells to silence antigen specific cd8+t cell function
10/24/2002	WO2002040038A3 M. tuberculosis chaperonin 10 and uses thereof
10/24/2002	WO2002026258A3 Treatment of immune-mediated diseases by oral administration of plasma fractions
10/24/2002	WO2002024729A3 Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use
10/24/2002	WO2002017935A3 A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
10/24/2002	WO2001074848A3 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use
10/24/2002	WO2001059073A9 Cytotoxic t lymphocytes activated by dendritic cell hybrids
10/24/2002	WO2001058526A9 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
10/24/2002	US20020157121 Propagation of human hepatocytes in non-human animals
10/24/2002	US20020156773 Soluble HLA ligand database utilizing predictive algorithms and methods of making and using same
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156258 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
10/24/2002	US20020156252 Novel Stra6 polypeptides
10/24/2002	US20020156251 Fusion protein for use in the treatment and prevention of viral diseases
10/24/2002	US20020156246 15625 receptor, a novel G-protein coupled receptor
10/24/2002	US20020156037 DNA vaccine formulations
10/24/2002	US20020156036 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier
10/24/2002	US20020156035 NET-4 is a member of the tetraspan transmembrane receptor family; antisense molecules, ribozymes, antibodies and antibody fragments for reductin NET-4 gene expression or activity; antitumor agents
10/24/2002	US20020156033 Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
10/24/2002	US20020156011 One or more colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, may comprise an antigen presenting cell that expresses a colon tumor protein
10/24/2002	US20020156006 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/24/2002	US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use
10/24/2002	US20020155997 Biologically active material isolated from non-pathogenic bacteria, such as Enterobacteriaceae
10/24/2002	US20020155987 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/24/2002	US20020155609 Monocyte-specific particulate delivery vehicle
10/24/2002	US20020155596 Recombinant vaccinia virus incorporated with gene coding glutamic acid decarboxylase and vaccine for preventing type 1 diabetes mellitus comprising the same

1 ... 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 ... 1823